Healthcare and Life Sciences Value & Outcomes Assessment

Capabilities

• Real-World Evidence Consulting

  We help life sciences companies derive real-world evidence (RWE) insights from fit-for-purpose real-world data (RWD) for more informed decision-making to bring innovative medicines to market, improve patient outcomes, and fulfill regulatory requirements. 

  Learn more

• Market Access Strategy

  Our team helps life sciences companies differentiate their products by evaluating regulatory, human factors, or market adoption strategies intended to facilitate market adoption and accelerate return on investment (ROI). Building on technical assessments and scientific insights, Exponent also helps companies build strategies for reimbursement and to inform pricing negotiations via budget impact or cost-effectiveness models for healthcare payers. 

• Next-Gen Partnerships

  Exponent enables life sciences companies to engage in non-traditional strategic partnerships (e.g., beyond payer/provider partners) intended to gain access to more diverse and inclusive real-world insights, especially for rare diseases and complex indications.

• Expanding Health Equity

  Our expertise includes helping life sciences companies expand diversity initiatives to include underrepresented populations in their clinical trials and RWE studies to strengthen the body of evidence for healthcare products for all relevant populations and improve outcomes for patients, health systems, regulator, and manufacturers.

• Digital Health

  We partner with life sciences companies to develop and implement digital endpoints from strategy to validation, including regulatory submissions, understanding reimbursement pathways, and choosing the appropriate digital health technology (DHT) for outcome assessment. These services range from identifying the right technology to assessing human factors, clinical viability, maturity, participant usability, and the validity of the resulting data. 

  Learn more

• Regulatory Submission Support

  Our experts can devise an evidenced-based plan that includes RWE strategies and RWD assessment for regulatory submissions based on decades of generating RWE and working on complex regulatory submissions.